These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 12045738

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Neuronal injury in chronic CNS inflammation.
    Zindler E, Zipp F.
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [Abstract] [Full Text] [Related]

  • 3. Multiple sclerosis: an immune or neurodegenerative disorder?
    Trapp BD, Nave KA.
    Annu Rev Neurosci; 2008 Dec; 31():247-69. PubMed ID: 18558855
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis.
    Ziemssen T.
    J Neurol; 2005 Nov; 252 Suppl 5():v38-45. PubMed ID: 16254701
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Current trends in multiple sclerosis research: an update on pathogenic concepts.
    Vanderlocht J, Hellings N, Hendriks JJ, Stinissen P.
    Acta Neurol Belg; 2006 Dec; 106(4):180-90. PubMed ID: 17323836
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The future of multiple sclerosis treatment.
    Cohen JA.
    J Neurol Sci; 2009 Feb 01; 277 Suppl 1():S55-61. PubMed ID: 19200869
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.
    Wang D, Ayers MM, Catmull DV, Hazelwood LJ, Bernard CC, Orian JM.
    Glia; 2005 Aug 15; 51(3):235-40. PubMed ID: 15812814
    [Abstract] [Full Text] [Related]

  • 13. [Clinical and pathological topics of multiple sclerosis].
    Lassmann H.
    Rinsho Shinkeigaku; 2009 Nov 15; 49(11):715-8. PubMed ID: 20030193
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Advances in the immune pathogenesis and treatment of multiple sclerosis.
    Huang D, Rae-Grant A.
    Cent Nerv Syst Agents Med Chem; 2009 Mar 15; 9(1):20-31. PubMed ID: 20021335
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Natural products: Potential therapeutic agents in multiple sclerosis.
    Yu S, Liu M, Hu K.
    Int Immunopharmacol; 2019 Feb 15; 67():87-97. PubMed ID: 30537635
    [Abstract] [Full Text] [Related]

  • 18. New drug therapies for multiple sclerosis.
    Mangas A, Coveñas R, Geffard M.
    Curr Opin Neurol; 2010 Jun 15; 23(3):287-92. PubMed ID: 20414110
    [Abstract] [Full Text] [Related]

  • 19. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.
    Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Brück W.
    Brain; 2000 Jun 15; 123 ( Pt 6)():1174-83. PubMed ID: 10825356
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.